$ZIOP ZIOPHARM ONCOLOGY INC Insider Trading Week 52/2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ZIOPHARM ONCOLOGY INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ZIOPHARM ONCOLOGY INC in week 52/2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Tarriff Scott | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Option Exercise | A | 4.72 | 25,281 | 119,326 | 25,281 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Payment of Exercise | F | 4.72 | 20,054 | 94,655 | 35,943 | 56 K to 35.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Pagan Douglas W. | Director | Grant | A | 0.00 | 15,890 | 0 | 55,997 | 40.1 K to 56 K (+39.62 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | MAUNEY DAVID M MD | President | Sell | S | 4.55 | 22,394 | 101,893 | 195,278 | 217.7 K to 195.3 K (-10.29 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | SVP, Treasurer & CA ... | Option Exercise | A | 4.72 | 48,000 | 226,560 | 48,000 | |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Lafond Kevin G | SVP, Treasurer & CA ... | Sell | S | 4.55 | 21,570 | 98,144 | 63,985 | 85.6 K to 64 K (-25.21 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hagen Heidi | Director | Grant | A | 0.00 | 31,780 | 0 | 32,119 | 339 to 32.1 K (+9,374.63 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Hadfield Robert | General Counsel and ... | Sell | S | 4.55 | 16,853 | 76,681 | 100,719 | 117.6 K to 100.7 K (-14.33 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Payment of Exercise | F | 4.72 | 40,107 | 189,305 | 71,887 | 112 K to 71.9 K (-35.81 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Ezickson Elan | Director | Grant | A | 0.00 | 31,780 | 0 | 111,994 | 80.2 K to 112 K (+39.62 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | De Groot Eleanor | EVP, GM Cell Therap ... | Sell | S | 4.55 | 24,890 | 113,250 | 174,333 | 199.2 K to 174.3 K (-12.49 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Buck Jill | EVP, GM Gene Therap ... | Sell | S | 4.55 | 27,923 | 127,050 | 173,710 | 201.6 K to 173.7 K (-13.85 %) |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Braunstein Scott | Director | Grant | A | 0.00 | 31,780 | 0 | 31,780 | 0 to 31.8 K |
| Jan 03 2020 | ZIOP | ZIOPHARM ONCOLOGY ... | Bowden Christopher | Director | Option Exercise | A | 4.72 | 50,562 | 238,653 | 50,562 | |
| Dec 31 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Option Exercise | M | 2.24 | 44,642 | 99,998 | 487,171 | |
| Dec 31 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Sell | S | 4.88 | 110,694 | 540,187 | 1,733,273 | 1.8 M to 1.7 M (-6.00 %) |
| Dec 31 2019 | ZIOP | ZIOPHARM ONCOLOGY ... | Cooper Laurence James Neil | Chief Executive Off ... | Buy | M | 2.24 | 44,642 | 99,998 | 1,843,967 | 1.8 M to 1.8 M (+2.48 %) |